Are you Dr. Fine?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
330 Mount Auburn St
Cambridge, MA 02138Phone+1 617-499-5112Fax+1 617-575-8608
Summary
- Dr. Gregg Fine, MD is an oncologist in Cambridge, Massachusetts. He is currently licensed to practice medicine in Massachusetts and California.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2002 - 2005
- University of Vermont College of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2010 - 2023
- MA State Medical License 2005 - 2012
Publications & Presentations
PubMed
- 3214 citationsTGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Sanjeev Mariathasan, Shannon J. Turley, Dorothee Nickles, Alessandra Castiglioni, Kobe C. Yuen
Nature. 2018-02-22 - 1472 citationsAtezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg, Thomas Powles, Daniel P. Petrylak
Lancet. 2017-01-07 - 420 citationsAtezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase I...David F. McDermott, Jeffrey A. Sosman, Mario Sznol, Christophe Massard, Michael S. Gordon
Journal of Clinical Oncology. 2016-09-19
Press Mentions
- A Door OpensNovember 11th, 2016